New Mailing Standards for COVID-19 Related Category B Infectious Substances, 23745-23746 [2020-08256]
Download as PDF
Federal Register / Vol. 85, No. 83 / Wednesday, April 29, 2020 / Rules and Regulations
Staff Chairperson may waive the filing
fee in whole or in part and will notify
the parties in writing. No waiver shall
be implied, even where the Staff
Chairperson does not reject a voluntary
notice under § 802.1108 for failure to
pay the required filing fee.
§ 802.1107
Refilings.
The parties to a transaction shall not
be required to pay an additional filing
fee in the event that the Staff
Chairperson permits the parties to
withdraw and refile a notice under
§ 802.509(c)(2), unless the Staff
Chairperson determines that a material
change to the transaction has occurred,
or a material inaccuracy or omission
was made by the parties in information
provided to the Committee, that requires
the Committee to consider new
information, in which case the Staff
Chairperson will inform the parties in
writing.
§ 802.1108
Rejection of voluntary notice.
The Staff Chairperson may reject a
voluntary notice under § 802.504(a)(3)
upon a determination that the amount of
the filing fee paid by the parties was
insufficient under this subpart. Prior to
rejecting a notice under § 802.504(a)(3),
the Staff Chairperson shall inform the
parties in writing of the insufficiency of
payment and provide the parties three
business days to pay the remainder of
the filing fee. If the Staff Chairperson
does not reject a voluntary notice under
§ 802.504(a)(3) upon a determination
that the amount of the filing fee
payment paid by the parties was
insufficient under this section, the
balance of the fee remains payable
unless the Staff Chairperson notifies the
parties in writing that the payment has
been waived in whole or in part.
Dated: April 22, 2020.
Thomas Feddo,
Assistant Secretary for Investment Security.
[FR Doc. 2020–08916 Filed 4–28–20; 8:45 am]
BILLING CODE 4810–25–P
POSTAL SERVICE
39 CFR Part 113
New Mailing Standards for COVID–19
Related Category B Infectious
Substances
Postal ServiceTM.
Temporary final rule.
jbell on DSKJLSW7X2PROD with RULES
AGENCY:
ACTION:
The Postal Service is revising
its Hazardous, Restricted and Perishable
Mail regulations by replacing
Publication 52, Hazardous, Restricted,
and Perishable Mail, Appendix C,
SUMMARY:
VerDate Sep<11>2014
16:00 Apr 28, 2020
Jkt 250001
Packaging Instructions 6C, currently
incorporated by reference, to support
the rapid deployment of coronavirus
(COVID–19) diagnostic tests using the
mail during this public health
emergency. In addition to the updated
packaging instructions, all shippers of
COVID–19 related Infectious Substances
Category B UN3373 must obtain
authorization from the Postal Service
prior to mailing. These measures are
necessary to ensure that diagnostic kits
potentially containing Category B
Infectious Substances are packaged,
marked and labelled properly to ensure
safety and containment throughout
transport.
DATES: Effective: April 27, 2020 until the
Federal public health emergency first
declared on March 13, 2020 is
terminated (following procedures
prescribed in 50 U.S. Code § 1622). The
Postal Service will publish a document
announcing the termination date in the
Federal Register.
FOR FURTHER INFORMATION CONTACT:
Mary J. Collins at (202) 268–5551 or
Dale Kennedy at (202) 268–6592 or by
email at pcfederalregister@usps.gov.
SUPPLEMENTARY INFORMATION:
Overview
The United States Postal Service is
currently experiencing a greater demand
for the transportation of Infectious
Substances, Category B UN3373 as a
result of the ongoing COVID–19
pandemic. Due to the infectious nature
of these materials, there exists a need for
higher levels of awareness, safety and
compliance in order to protect our
employees, customers, and
transportation partners.
When a package containing infectious
substances is moved between the point
of origin and its destination, it may be
subjected to physical challenges,
including movement, vibration, and
changes of temperature, humidity and
pressure. It is therefore, essential that
the packaging used to contain infectious
substances meets all required standards,
and is able to withstand the normal
conditions of transportation. It is the
responsibility of the shipper to ensure
they comply with all applicable
regulations. The revisions will provide
conformity and harmonization with
other regulatory entities, prevent the
shipment of fraudulent test kits in the
mail, and reduce risk to employees and
the general public by preventing
exposure to this infectious substance.
The current packaging requirements
incorporated by reference in Publication
52 Appendix C, Packaging Instruction
6C are replaced with new required
shipper authorization and updated
PO 00000
Frm 00015
Fmt 4700
Sfmt 4700
23745
packaging requirements added as
§ 113.3. Section 113.3 will be in place
until the end of this public health
emergency.
The Postal Service will publish a
document announcing the termination
date in the Federal Register. If you want
to know whether this rule has been
terminated, email or call either person
identified in FOR FURTHER INFORMATION
CONTACT.
The specific requirements to be used
in place of Appendix C, Packaging
Instruction 6C to Publication 52,
Hazardous, Restricted, and Perishable
Mail adopted in this document will be
published in Postal Bulletin 22544 on
April 23, 2020, and can be viewed at
https://about.usps.com/postal-bulletin.
List of Subjects in Part 113
Administrative practice and
procedure, Postal Service.
For the reasons set forth above, the
Postal Service amends 39 CFR part 113
as follows:
PART 113—HAZARDOUS,
RESTRICTED, AND PERISHABLE MAIL
1. The authority citation for part 113
continues to read as follows:
■
Authority: 5 U.S.C. 552(a); 13 U.S.C. 301–
307; 18 U.S.C. 1692–1737; 39 U.S.C. 101,
401, 403, 404, 414, 416, 3001–3011, 3201–
3219, 3403–3406, 3621, 3622, 3626, 3632,
3633, and 5001.
2. Amend § 113.1 by adding a final
sentence to read as follows:
■
§ 113.1
Scope and purpose.
* * * Follow the requirements of
§ 113.3 in place of Publication 52,
Appendix C, Packaging Instruction 6C.
■ 3. Add § 113.3 to read as follows:
§ 113.3 Mailing Standards for COVID–19
related Category B Infectious Substances.
(a) Required Shipper Authorization.
(1) All shippers of COVID–19 related
Infectious Substances Category B must
obtain an authorization from the Postal
Service prior to mailing. It is the
responsibility of the shipper to ensure
that they are aware of, and comply with,
all other applicable requirements and
regulations for the mailing of these
materials; and they must be able to
provide evidence of compliance before
a written request is submitted to the
manager of Product Classification,
Postal Service Headquarters.
(2) Under this section, only tests
developed and being performed by
laboratories certified under the Clinical
Laboratory Improvement Amendments
(CLIA) or equivalent clinical oversight
regulations, and commercial tests and
home collection kits authorized by
E:\FR\FM\29APR1.SGM
29APR1
jbell on DSKJLSW7X2PROD with RULES
23746
Federal Register / Vol. 85, No. 83 / Wednesday, April 29, 2020 / Rules and Regulations
either the FDA or an Institutional
Review Board will be considered for
mailing.
(b) Required Packaging. The materials
must be triple-packaged, meeting the
packaging requirements in 49 CFR
173.199. Such materials must be
properly packaged to withstand shocks,
pressure changes, and other conditions
related to ordinary handling in transit,
and surrounded by absorbent material
sufficient to protect the primary
receptacle and to absorb the total
amount of liquid should the primary
receptacle leak or break. The outer
packaging must be of adequate size to
accommodate all required shipping
information and marks and will include
the size of the mark on each side must
not be less than 50 mm (1.97 inches) in
length, the width of the border lines at
least 2 mm, and letter and numbers
must be at least 6 mm (0.24 inches)
high.
(c) Package Drop Test. The completed
triple packaging must be capable of
successfully passing the drop test in 49
CFR 178.609(d) at a drop height of at
least 1.2 meters (3.9 feet). Following the
drop test, there must be no leakage from
the primary receptacle, which must
remain protected by absorbent material,
when required, in the secondary
packaging.
(d) Instructions. Shippers must
provide clear instructions to users
regarding the procedures to be followed
for preparing the samples and packaging
used to transport an Infectious
Substance Category B. Shippers must
instruct users to adhere to all applicable
mail related preparation requirements
before mailing, to ensure the package is
properly prepared for safe
transportation.
(e) Optional Outer Packaging. A
polybag covering may be acceptable as
the outer packaging, providing that the
interior triple packaging is complete, the
selvage edge of the wrapping is less than
2 inches, all required markings and
address information are applied both on
the interior rigid box and the additional
outer polybag wrapping.
(f) Use of a Refrigerant (If Applicable).
(1) Only cold packs or dry ice may be
used as a refrigerant and must be placed
outside of the secondary packaging.
Interior supports must be provided to
secure the secondary packaging in the
original position. If a cold pack is used,
the packaging must be leak-proof. If dry
ice is used, the outside packaging must
permit the release of carbon dioxide gas
and otherwise meet the provisions in 49
CFR 173.217. The primary receptacle
and secondary packaging must maintain
their integrity at the temperature of the
refrigerant used, as well as the
VerDate Sep<11>2014
16:00 Apr 28, 2020
Jkt 250001
temperatures and pressures of transport
by aircraft they could be subjected to if
refrigeration were lost, and sufficient
absorbent material must be provided to
absorb all liquid, including melted ice.
(2) When dry ice is used, the package
must include the markings ‘‘Carbon
dioxide, solid’’ or ‘‘Dry ice’’ and an
indication that the material being
refrigerated is used for diagnostic or
treatment purposes (e.g., frozen medical
specimens). Marking requirements in
USPS Packaging Instruction 9A are not
applicable.
(g) Other Allowance. Only small
quantities of Class 3, Class 8, Class 9, or
other materials in Packing Groups II and
III may be used to stabilize or prevent
degradation of the sample, provided the
quantity of such materials does not
exceed 30 mL (1 ounce) or 30 g (1
ounce) in each inner packaging.
Joshua J. Hofer,
Attorney, Federal Compliance.
[FR Doc. 2020–08256 Filed 4–27–20; 11:15 am]
BILLING CODE 7710–12–P
DEPARTMENT OF COMMERCE
National Oceanic and Atmospheric
Administration
50 CFR Part 679
[Docket No. 200227–0066; RTID 0648–
XY093]
Fisheries of the Exclusive Economic
Zone Off Alaska; Greenland Turbot in
the Aleutian Islands Subarea of the
Bering Sea and Aleutian Islands
Management Area
National Marine Fisheries
Service (NMFS), National Oceanic and
Atmospheric Administration (NOAA),
Commerce.
ACTION: Temporary rule; closure.
AGENCY:
NMFS is prohibiting directed
fishing for Greenland turbot in the
Aleutian Islands subarea of the Bering
Sea and Aleutian Islands management
area (BSAI). This action is necessary to
prevent exceeding the 2020 Greenland
turbot initial total allowable catch
(ITAC) in the Aleutian Islands subarea
of the BSAI.
DATES: Effective 1200 hours, Alaska
local time (A.l.t.), May 1, 2020, through
2400 hours, A.l.t., December 31, 2020.
FOR FURTHER INFORMATION CONTACT:
Steve Whitney, 907–586–7228.
SUPPLEMENTARY INFORMATION: NMFS
manages the groundfish fishery in the
BSAI according to the Fishery
Management Plan for Groundfish of the
SUMMARY:
PO 00000
Frm 00016
Fmt 4700
Sfmt 4700
Bering Sea and Aleutian Islands
Management Area (FMP) prepared by
the North Pacific Fishery Management
Council under authority of the
Magnuson-Stevens Fishery
Conservation and Management Act.
Regulations governing fishing by U.S.
vessels in accordance with the FMP
appear at subpart H of 50 CFR part 600
and 50 CFR part 679.
The 2020 Greenland turbot ITAC in
the Aleutian Islands subarea of the BSAI
is 149 metric tons (mt) as established by
the final 2020 and 2021 harvest
specifications for groundfish in the
BSAI (85 FR 13553, March 9, 2020). The
Regional Administrator has determined
that the 2020 ITAC for Greenland turbot
in the Aleutian Islands subarea of the
BSAI is necessary to account for the
incidental catch of this species in other
anticipated groundfish fisheries for the
2020 fishing year. Therefore, in
accordance with § 679.20(d)(1)(i), the
Regional Administrator establishes the
directed fishing allowance for
Greenland turbot in the Aleutian Islands
subarea of the BSAI as zero mt.
Consequently, in accordance with
§ 679.20(d)(1)(iii), NMFS is prohibiting
directed fishing for Greenland turbot in
the Aleutian Islands subarea of the
BSAI.
While this closure is effective, the
maximum retainable amounts at
§ 679.20(e) and (f) apply at any time
during a trip.
Classification
This action responds to the best
available information recently obtained
from the fishery. The Assistant
Administrator for Fisheries, NOAA
(AA), finds good cause to waive the
requirement to provide prior notice and
opportunity for public comment
pursuant to the authority set forth at 5
U.S.C. 553(b)(B) as such requirement is
impracticable and contrary to the public
interest. This requirement is
impracticable and contrary to the public
interest as it would prevent NMFS from
responding to the most recent fisheries
data in a timely fashion and would
delay the directed fishing closure of
Greenland turbot in the Aleutian Islands
subarea of the BSAI. Since the fishery
opens May 1, 2020, it is important to
immediately inform the industry to
allow for the orderly conduct and
efficient operation of other fisheries
currently operating in this area; allow
the industry to plan for the fishing
season and avoid potential disruption to
the fishing fleet. NMFS was unable to
publish a notice providing time for
public comment because the most
recent, relevant data only became
available as of April 15, 2020.
E:\FR\FM\29APR1.SGM
29APR1
Agencies
[Federal Register Volume 85, Number 83 (Wednesday, April 29, 2020)]
[Rules and Regulations]
[Pages 23745-23746]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08256]
=======================================================================
-----------------------------------------------------------------------
POSTAL SERVICE
39 CFR Part 113
New Mailing Standards for COVID-19 Related Category B Infectious
Substances
AGENCY: Postal ServiceTM.
ACTION: Temporary final rule.
-----------------------------------------------------------------------
SUMMARY: The Postal Service is revising its Hazardous, Restricted and
Perishable Mail regulations by replacing Publication 52, Hazardous,
Restricted, and Perishable Mail, Appendix C, Packaging Instructions 6C,
currently incorporated by reference, to support the rapid deployment of
coronavirus (COVID-19) diagnostic tests using the mail during this
public health emergency. In addition to the updated packaging
instructions, all shippers of COVID-19 related Infectious Substances
Category B UN3373 must obtain authorization from the Postal Service
prior to mailing. These measures are necessary to ensure that
diagnostic kits potentially containing Category B Infectious Substances
are packaged, marked and labelled properly to ensure safety and
containment throughout transport.
DATES: Effective: April 27, 2020 until the Federal public health
emergency first declared on March 13, 2020 is terminated (following
procedures prescribed in 50 U.S. Code Sec. 1622). The Postal Service
will publish a document announcing the termination date in the Federal
Register.
FOR FURTHER INFORMATION CONTACT: Mary J. Collins at (202) 268-5551 or
Dale Kennedy at (202) 268-6592 or by email at
[email protected].
SUPPLEMENTARY INFORMATION:
Overview
The United States Postal Service is currently experiencing a
greater demand for the transportation of Infectious Substances,
Category B UN3373 as a result of the ongoing COVID-19 pandemic. Due to
the infectious nature of these materials, there exists a need for
higher levels of awareness, safety and compliance in order to protect
our employees, customers, and transportation partners.
When a package containing infectious substances is moved between
the point of origin and its destination, it may be subjected to
physical challenges, including movement, vibration, and changes of
temperature, humidity and pressure. It is therefore, essential that the
packaging used to contain infectious substances meets all required
standards, and is able to withstand the normal conditions of
transportation. It is the responsibility of the shipper to ensure they
comply with all applicable regulations. The revisions will provide
conformity and harmonization with other regulatory entities, prevent
the shipment of fraudulent test kits in the mail, and reduce risk to
employees and the general public by preventing exposure to this
infectious substance.
The current packaging requirements incorporated by reference in
Publication 52 Appendix C, Packaging Instruction 6C are replaced with
new required shipper authorization and updated packaging requirements
added as Sec. 113.3. Section 113.3 will be in place until the end of
this public health emergency.
The Postal Service will publish a document announcing the
termination date in the Federal Register. If you want to know whether
this rule has been terminated, email or call either person identified
in FOR FURTHER INFORMATION CONTACT.
The specific requirements to be used in place of Appendix C,
Packaging Instruction 6C to Publication 52, Hazardous, Restricted, and
Perishable Mail adopted in this document will be published in Postal
Bulletin 22544 on April 23, 2020, and can be viewed at https://about.usps.com/postal-bulletin.
List of Subjects in Part 113
Administrative practice and procedure, Postal Service.
For the reasons set forth above, the Postal Service amends 39 CFR
part 113 as follows:
PART 113--HAZARDOUS, RESTRICTED, AND PERISHABLE MAIL
0
1. The authority citation for part 113 continues to read as follows:
Authority: 5 U.S.C. 552(a); 13 U.S.C. 301-307; 18 U.S.C. 1692-
1737; 39 U.S.C. 101, 401, 403, 404, 414, 416, 3001-3011, 3201-3219,
3403-3406, 3621, 3622, 3626, 3632, 3633, and 5001.
0
2. Amend Sec. 113.1 by adding a final sentence to read as follows:
Sec. 113.1 Scope and purpose.
* * * Follow the requirements of Sec. 113.3 in place of
Publication 52, Appendix C, Packaging Instruction 6C.
0
3. Add Sec. 113.3 to read as follows:
Sec. 113.3 Mailing Standards for COVID-19 related Category B
Infectious Substances.
(a) Required Shipper Authorization. (1) All shippers of COVID-19
related Infectious Substances Category B must obtain an authorization
from the Postal Service prior to mailing. It is the responsibility of
the shipper to ensure that they are aware of, and comply with, all
other applicable requirements and regulations for the mailing of these
materials; and they must be able to provide evidence of compliance
before a written request is submitted to the manager of Product
Classification, Postal Service Headquarters.
(2) Under this section, only tests developed and being performed by
laboratories certified under the Clinical Laboratory Improvement
Amendments (CLIA) or equivalent clinical oversight regulations, and
commercial tests and home collection kits authorized by
[[Page 23746]]
either the FDA or an Institutional Review Board will be considered for
mailing.
(b) Required Packaging. The materials must be triple-packaged,
meeting the packaging requirements in 49 CFR 173.199. Such materials
must be properly packaged to withstand shocks, pressure changes, and
other conditions related to ordinary handling in transit, and
surrounded by absorbent material sufficient to protect the primary
receptacle and to absorb the total amount of liquid should the primary
receptacle leak or break. The outer packaging must be of adequate size
to accommodate all required shipping information and marks and will
include the size of the mark on each side must not be less than 50 mm
(1.97 inches) in length, the width of the border lines at least 2 mm,
and letter and numbers must be at least 6 mm (0.24 inches) high.
(c) Package Drop Test. The completed triple packaging must be
capable of successfully passing the drop test in 49 CFR 178.609(d) at a
drop height of at least 1.2 meters (3.9 feet). Following the drop test,
there must be no leakage from the primary receptacle, which must remain
protected by absorbent material, when required, in the secondary
packaging.
(d) Instructions. Shippers must provide clear instructions to users
regarding the procedures to be followed for preparing the samples and
packaging used to transport an Infectious Substance Category B.
Shippers must instruct users to adhere to all applicable mail related
preparation requirements before mailing, to ensure the package is
properly prepared for safe transportation.
(e) Optional Outer Packaging. A polybag covering may be acceptable
as the outer packaging, providing that the interior triple packaging is
complete, the selvage edge of the wrapping is less than 2 inches, all
required markings and address information are applied both on the
interior rigid box and the additional outer polybag wrapping.
(f) Use of a Refrigerant (If Applicable). (1) Only cold packs or
dry ice may be used as a refrigerant and must be placed outside of the
secondary packaging. Interior supports must be provided to secure the
secondary packaging in the original position. If a cold pack is used,
the packaging must be leak-proof. If dry ice is used, the outside
packaging must permit the release of carbon dioxide gas and otherwise
meet the provisions in 49 CFR 173.217. The primary receptacle and
secondary packaging must maintain their integrity at the temperature of
the refrigerant used, as well as the temperatures and pressures of
transport by aircraft they could be subjected to if refrigeration were
lost, and sufficient absorbent material must be provided to absorb all
liquid, including melted ice.
(2) When dry ice is used, the package must include the markings
``Carbon dioxide, solid'' or ``Dry ice'' and an indication that the
material being refrigerated is used for diagnostic or treatment
purposes (e.g., frozen medical specimens). Marking requirements in USPS
Packaging Instruction 9A are not applicable.
(g) Other Allowance. Only small quantities of Class 3, Class 8,
Class 9, or other materials in Packing Groups II and III may be used to
stabilize or prevent degradation of the sample, provided the quantity
of such materials does not exceed 30 mL (1 ounce) or 30 g (1 ounce) in
each inner packaging.
Joshua J. Hofer,
Attorney, Federal Compliance.
[FR Doc. 2020-08256 Filed 4-27-20; 11:15 am]
BILLING CODE 7710-12-P